Early research (Phase 1)Ended earlyNCT01409174What this trial is testingIPI Biochemotherapy for Chemonaive Patients With Metastatic MelanomaWho this might be right forMelanoma M.D. Anderson Cancer Center 19
Early research (Phase 1)Looking for participantsNCT04119024What this trial is testingGene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsWho this might be right forMetastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more Anusha Kalbasi 18
Early research (Phase 1)Study completedNCT00688090What this trial is testingSafety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma.Who this might be right forAdvanced MelanomaStage III and IV Melanoma Mannkind Corporation 19
Early research (Phase 1)Ended earlyNCT02327390What this trial is testingEx Vivo-Activated Lymph Node Lymphocytes in Treating Patients With Stage IIIC-IV MelanomaWho this might be right forStage IIIC Skin MelanomaStage IV Melanoma Case Comprehensive Cancer Center 3
Not applicableUnknownNCT05402059What this trial is testingClinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical PracticeWho this might be right forMelanomaMelanoma (Skin)Melanoma, Uveal+5 more MelanomaPRO, Russia 1,570
Testing effectiveness (Phase 2)UnknownNCT00811759What this trial is testingSorafenib and Temozolomide in Treating Patients With Stage III or Stage IV MelanomaWho this might be right forMelanoma (Skin) Gustave Roussy, Cancer Campus, Grand Paris 58
Testing effectiveness (Phase 2)Ended earlyNCT04527549What this trial is testingTesting Dabrafenib and Trametinib With or Without Hydroxychloroquine in Stage IIIC or IV BRAF V600E/K MelanomaWho this might be right forClinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+2 more ECOG-ACRIN Cancer Research Group 5
Testing effectiveness (Phase 2)Study completedNCT00118274What this trial is testingVaccine Therapy With or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV MelanomaWho this might be right forMelanoma (Skin) Craig L Slingluff, Jr 170
Testing effectiveness (Phase 2)Study completedNCT01376713What this trial is testingAnti-CD20 (Cluster of Differentiation Antigen 20) Therapy to Treat Metastatic MelanomaWho this might be right forStage III MelanomaStage IV Melanoma Medical University of Vienna 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT02231775What this trial is testingDabrafenib and Trametinib Before and After Surgery in Treating Patients With Stage IIIB-C Melanoma With BRAF V600 MutationWho this might be right forStage IIIB Cutaneous Melanoma AJCC v7Stage IIIC Cutaneous Melanoma AJCC v7 M.D. Anderson Cancer Center 58
Large-scale testing (Phase 3)Study completedNCT01689519What this trial is testingA Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic MelanomaWho this might be right forMalignant Melanoma Hoffmann-La Roche 495
Testing effectiveness (Phase 2)Active Not RecruitingNCT04356729What this trial is testingA Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic MelanomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Stage IV MelanomaUnresectable Stage III Cutaneous Melanoma+1 more F. Stephen Hodi, MD 30
Testing effectiveness (Phase 2)Study completedNCT03743766What this trial is testingNivolumab, BMS-936558 in Combination With Relatlimab, BMS-986016 in Patients With Metastatic Melanoma Naïve to Prior Immunotherapy in the Metastatic SettingWho this might be right forMelanoma John Kirkwood 43
Testing effectiveness (Phase 2)Ended earlyNCT01026051What this trial is testingSafety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With MelanomaWho this might be right forStage III MelanomaStage IV Melanoma Mannkind Corporation 5
Post-approval studies (Phase 4)UnknownNCT05467137What this trial is testingSentinel Lymph Node Detection in Patients With Stage Ib-III Melanoma Using MSOT and ICGWho this might be right forMelanoma, Stage IMelanoma, Stage IIMelanoma Stage III University Medical Center Groningen 10
Testing effectiveness (Phase 2)UnknownNCT05907512What this trial is testingEndostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous MelanomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8 Fudan University 43
Not applicableStudy completedNCT00937781What this trial is testingStudy of Tumor Tissue From Patients With Melanoma Treated on Clinical Trial EST-1690Who this might be right forMelanoma (Skin) ECOG-ACRIN Cancer Research Group 307
Testing effectiveness (Phase 2)Study completedNCT00794235What this trial is testingMonocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and DacarbazineWho this might be right forMelanoma Stage III or IVNo Prior Chemotherapy University of Zurich 12
Early research (Phase 1)WithdrawnNCT06190249What this trial is testingEfficacy & Safety for LN144 With Pembrolizumab With High Risk Stage IIIb-dResectable MelanomaWho this might be right forStage IIIB MelanomaStage IIIC MelanomaStage IIID Melanoma James Isaacs, MD
Early research (Phase 1)Study completedNCT02077114What this trial is testingVaccination With Peptides in Combination With Either Ipilimumab or Vemurafenib for the Treatment of Unresectable Stage III or IV Malignant MelanomaWho this might be right forMalignant Melanoma With Metastasis Herlev Hospital 10